Your Location:
Home >
Browse articles >
Mechanism of Huangqi Chifengtang in Treating Atherosclerosis Based on 16S rRNA Sequencing and Metabolomics
Mechanism of Huangqi Chifengtang in Treating Atherosclerosis Based on 16S rRNA Sequencing and Metabolomics
Enhanced Publication- “The latest research found that Huangqi Chifeng Decoction can improve the dyslipidemia and inflammatory reaction of atherosclerosis rats by regulating intestinal flora and metabolites.”
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 31, Issue 13, Pages: 94-103(2025)
DOI: 10.13422/j.cnki.syfjx.20240718
Accepted:10 November 2024
Scan QR Code
AI Introduction
Full Text(HTML)
Figs( 1 ) Tabs( 7 )
References
Publication Info
Metrics
480
Views
332
Downloads
2
CSCD
Alert me when the article has been cited
Submit
Tools
- BibTeXDownload
- EndnoteDownload
- RefMan Download
- NoteExpressDownload
- NoteFirstDownload
Related Articles
Mechanism of Wendan Tang Against Atherosclerosis by Regulating Ferroptosis Based on JAK2/STAT3 Signaling Pathway
Iron Homeostasis Imbalance Promotes Atherosclerosis and Therapeutic Mechanisms of Traditional Chinese Medicine
Mechanism of Huoxin Pills in Stabilizing Atherosclerotic Vulnerable Plaque Based on Network Pharmacology and Metabolomics
Differentiation and Treatment of Vulnerable Atherosclerotic Plaque Based on "Collateral Disease" Theory
Polygonati Rhizoma Polysaccharides Improve Cognitive and Emotional Functions of Ovariectomy-AD Model Rats Through Modulating ERα/PI3K/Akt Pathway
Related Author
QIU Tingting
OUYANG Xiaoqiang
FANG Bangjiang
WANG Maohong
XIONG Jianhua
ZHANG Hao
YAN Xiaohong
WAN Qiang
Related Institution
Jiangxi University of Chinese Medicine
The Affiliated Hospital of Jiangxi University of Chinese Medicine
Longhua Hospital Shanghai University of Traditional Chinese Medicine
School of Chinese Materia Medica,Guangzhou University of Chinese Medicine
Baiyunshan Pharmaceutical General Factory, Guangzhou Baiyunshan Pharmaceutical Holdings Co. Ltd.


